Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

48.50p
   
  • Change Today:
    -1.25p
  • 52 Week High: 64.00
  • 52 Week Low: 40.00
  • Currency: UK Pounds
  • Shares Issued: 703.96m
  • Volume: 6,258
  • Market Cap: £341.42m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Mar-22 Interim 79.25 (5.14) (1.32)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-17 140.17 (8.10) (1.43)p n/a n/a n/a n/a 0.0%
30-Sep-18 131.64 (8.43) (0.03)p n/a n/a n/a n/a 0.0%
30-Sep-19 124.01 (58.48) (10.72)p n/a n/a n/a n/a 0.0%
30-Sep-20 105.57 (22.57) (3.80)p n/a n/a n/a n/a 0.0%
30-Sep-21 125.06 (9.18) (1.93)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-22 153.30 (4.69) (1.20)p n/a n/a n/a n/a 0.0%
30-Sep-23 172.86 3.72 (0.09)p n/a n/a n/a n/a 0.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

BMK Market Data

Currency UK Pounds
Share Price 48.50p
Change Today -1.25p
% Change -2.51 %
52 Week High 64.00
52 Week Low 40.00
Volume 6,258
Shares Issued 703.96m
Market Cap £341.42m

BMK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.19% below the market average13.19% below the market average13.19% below the market average13.19% below the market average13.19% below the market average
52.73% above the sector average52.73% above the sector average52.73% above the sector average52.73% above the sector average52.73% above the sector average
Price Trend
6.25% above the market average6.25% above the market average6.25% above the market average6.25% above the market average6.25% above the market average
68.25% above the sector average68.25% above the sector average68.25% above the sector average68.25% above the sector average68.25% above the sector average
Income Not Available
Growth
9.43% below the market average9.43% below the market average9.43% below the market average9.43% below the market average9.43% below the market average
55% below the sector average55% below the sector average55% below the sector average55% below the sector average55% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BMK Dividends

No dividends found

Trades for 24-Jun-2022

Time Volume / Share Price
16:35 70 @ 48.50p
14:51 955 @ 48.50p
14:20 217 @ 48.66p
10:13 5,000 @ 48.70p
10:01 6 @ 48.70p

BMK Key Personnel

CFO Septima Maguire
CEO Trond Williksen

Top of Page